MGMT and neuroblastoma: Pre-treatment with 25 μM O6-BG sensitised four out of the five tested neuroblastoma cell lines to TMZ by 0.3–1.4 logs (Figure 2); sensitising effect was not demonstrated in the highly drug-resistant CHLA-90 cells that lack MGMT expression.